Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 02, 2024 Filed May 6, 2024 22:23 UTC |
Tansey Casey MDirector
|
GrantCommon Stock | 716 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-057572 · tm2413647-7_4seq1.xml · nonDerivative · entry 1 Tansey Casey M · CIK 0001474322 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,260 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| May 02, 2024 Filed May 6, 2024 22:21 UTC |
Ellis Gary LeeDirector
|
GrantCommon Stock | 716 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-057571 · tm2413647-6_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,020 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| May 02, 2024 Filed May 6, 2024 22:16 UTC |
Mead Dana G Jr.Director
|
GrantCommon Stock | 716 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-057570 · tm2413647-5_4seq1.xml · nonDerivative · entry 1 Mead Dana G Jr. · CIK 0001222358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,385 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| May 02, 2024 Filed May 6, 2024 22:14 UTC |
Curet MyriamDirector
|
GrantCommon Stock | 716 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-057568 · tm2413647-4_4seq1.xml · nonDerivative · entry 1 Curet Myriam · CIK 0001632901 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,100 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| May 02, 2024 Filed May 6, 2024 22:08 UTC |
Broader Shelley GDirector
|
GrantCommon Stock | 716 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-057564 · tm2413647-2_4seq1.xml · nonDerivative · entry 1 Broader Shelley G. · CIK 0001426843 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,306 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| May 02, 2024 Filed May 6, 2024 22:05 UTC |
mcCormick ShawnDirector
|
GrantCommon Stock | 716 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-057563 · tm2413647-1_4seq1.xml · nonDerivative · entry 1 McCormick Shawn · CIK 0001454092 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,903 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 29, 2024 Filed May 1, 2024 20:01 UTC |
NELSON MARILYN CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,175 | $0.00 Strike: $240.68 | $0.00 |
DisclosureSEC source: 0001104659-24-055721 · tm2413236-1_4seq1.xml · derivative · entry 3 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,175 shares Expires 2031-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| April 29, 2024 Filed May 1, 2024 20:01 UTC |
NELSON MARILYN CDirector
|
Exercise / conversionCommon Stock | 1,175 | $240.68 | $282,799.00 |
DisclosureSEC source: 0001104659-24-055721 · tm2413236-1_4seq1.xml · nonDerivative · entry 1 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:44 UTC |
Buchholz RichardChief Financial Officer
|
GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048900 · tm2412174-1_4seq1.xml · nonDerivative · entry 6 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · By son Disclosed balance after: 1,350 Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:44 UTC |
Buchholz RichardChief Financial Officer
|
GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048900 · tm2412174-1_4seq1.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · By son Disclosed balance after: 1,350 Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:44 UTC |
Buchholz RichardChief Financial Officer
|
GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048900 · tm2412174-1_4seq1.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · By son Disclosed balance after: 1,350 Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:44 UTC |
Buchholz RichardChief Financial Officer
|
GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048900 · tm2412174-1_4seq1.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · By daughter Disclosed balance after: 1,350 Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:44 UTC |
Buchholz RichardChief Financial Officer
|
GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-048900 · tm2412174-1_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,771 Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:44 UTC |
Buchholz RichardChief Financial Officer
|
SaleCommon Stock | 15,000 | $230.03 | $3,450,450.00 |
DisclosureSEC source: 0001104659-24-048900 · tm2412174-1_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,271 F1 · kind: Reflects shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.00 to $230.82. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 21:13 UTC |
Melenikiotou GeorgiaDirector
|
GrantCommon Stock | 56 | $231.74 | $12,977.44 |
DisclosureSEC source: 0001104659-24-047881 · tm2411955-2_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,386 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 21:18 UTC |
Ellis Gary LeeDirector
|
GrantCommon Stock | 70 | $231.74 | $16,221.80 |
DisclosureSEC source: 0001104659-24-047895 · tm2411955-5_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,304 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 21:17 UTC |
Tansey Casey MDirector
|
GrantCommon Stock | 62 | $231.74 | $14,367.88 |
DisclosureSEC source: 0001104659-24-047892 · tm2411955-4_4seq1.xml · nonDerivative · entry 1 Tansey Casey M · CIK 0001474322 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,544 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 21:16 UTC |
Broader Shelley GDirector
|
GrantCommon Stock | 70 | $231.74 | $16,221.80 |
DisclosureSEC source: 0001104659-24-047888 · tm2411955-3_4seq1.xml · nonDerivative · entry 1 Broader Shelley G. · CIK 0001426843 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,590 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 21:11 UTC |
NELSON MARILYN CDirector
|
GrantCommon Stock | 107 | $231.74 | $24,796.18 |
DisclosureSEC source: 0001104659-24-047877 · tm2411955-1_4seq1.xml · nonDerivative · entry 1 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,445 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 00:29 UTC |
NELSON MARILYN CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,273 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-24-042745 · tm2410725-1_4seq1.xml · derivative · entry 3 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,313 Underlying: Common Stock · 3,273 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 00:29 UTC |
NELSON MARILYN CDirector
|
Exercise / conversionCommon Stock | 3,273 | $16.00 | $52,368.00 |
DisclosureSEC source: 0001104659-24-042745 · tm2410725-1_4seq1.xml · nonDerivative · entry 1 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 440 | $213.26 | $93,834.40 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 9 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 63,658 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.03 to $213.99. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 232 | $210.99 | $48,949.68 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 8 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 64,098 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.935 to $211.06. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 1,310 | $209.46 | $274,392.60 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 7 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 64,330 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.19 to $209.76. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 1,492 | $208.34 | $310,843.28 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 6 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 65,640 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.885 to $208.80. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 1,420 | $207.25 | $294,295.00 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 5 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 67,132 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.825 to $207.79. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 3,379 | $206.19 | $696,716.01 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 4 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 68,552 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.80 to $206.775. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 11,645 | $205.27 | $2,390,369.15 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 3 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 71,931 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.80 to $205.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 10,694 | $204.35 | $2,185,318.90 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 83,576 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.785 to $204.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 01:52 UTC Amendment |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 9,388 | $203.33 | $1,908,862.04 |
DisclosureSEC source: 0001104659-24-043288 · tm2411047-1_4aseq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 94,270 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.785 to $203.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 440 | $213.26 | $93,834.40 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 9 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 63,658 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.03 to $213.99. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 232 | $210.99 | $48,949.68 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 8 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 64,098 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.935 to $211.06. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 1,310 | $209.46 | $274,392.60 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 7 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 64,330 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.19 to $209.76. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 1,492 | $208.34 | $310,843.28 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 6 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 65,640 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.885 to $208.80. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 1,420 | $207.25 | $294,295.00 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 5 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 67,132 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.825 to $207.79. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 3,379 | $206.19 | $696,716.01 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 4 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 68,552 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.80 to $206.775. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 11,645 | $205.27 | $2,390,369.15 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 3 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 71,931 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.80 to $205.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 10,694 | $204.35 | $2,185,318.90 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 83,576 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.785 to $204.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 23:44 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 9,388 | $203.33 | $1,908,862.04 |
DisclosureSEC source: 0001104659-24-043244 · tm2411024-1_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 94,270 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.785 to $203.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:55 UTC |
Griffin Jerry CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 296 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-24-043142 · tm2410725-2_4seq1.xml · derivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 296 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:55 UTC |
Griffin Jerry CDirector
|
SaleCommon Stock | 32 | $213.99 | $6,847.68 |
DisclosureSEC source: 0001104659-24-043142 · tm2410725-2_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,900 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:55 UTC |
Griffin Jerry CDirector
|
Exercise / conversionCommon Stock | 296 | $16.00 | $4,736.00 |
DisclosureSEC source: 0001104659-24-043142 · tm2410725-2_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 20:49 UTC |
NELSON MARILYN CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-24-041175 · tm2410218-1_4seq1.xml · derivative · entry 5 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,586 Underlying: Common Stock · 2,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 20:49 UTC |
NELSON MARILYN CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,243 | $0.00 Strike: $211.29 | $0.00 |
DisclosureSEC source: 0001104659-24-041175 · tm2410218-1_4seq1.xml · derivative · entry 4 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,243 shares Expires 2032-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 20:49 UTC |
NELSON MARILYN CDirector
|
Exercise / conversionCommon Stock | 2,000 | $16.00 | $32,000.00 |
DisclosureSEC source: 0001104659-24-041175 · tm2410218-1_4seq1.xml · nonDerivative · entry 2 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 20:49 UTC |
NELSON MARILYN CDirector
|
Exercise / conversionCommon Stock | 1,243 | $211.29 | $262,633.47 |
DisclosureSEC source: 0001104659-24-041175 · tm2410218-1_4seq1.xml · nonDerivative · entry 1 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:01 UTC |
Griffin Jerry CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-24-039693 · tm249929-1_4seq1.xml · derivative · entry 4 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 296 Underlying: Common Stock · 1,000 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:01 UTC |
Griffin Jerry CDirector
|
SaleCommon Stock | 500 | $197.81 | $98,905.00 |
DisclosureSEC source: 0001104659-24-039693 · tm249929-1_4seq1.xml · nonDerivative · entry 3 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,636 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:01 UTC |
Griffin Jerry CDirector
|
SaleCommon Stock | 54 | $197.81 | $10,681.74 |
DisclosureSEC source: 0001104659-24-039693 · tm249929-1_4seq1.xml · nonDerivative · entry 2 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,136 F1 · kind: Reflects shares sold to cover taxes upon the option exercise pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:01 UTC |
Griffin Jerry CDirector
|
Exercise / conversionCommon Stock | 1,000 | $16.00 | $16,000.00 |
DisclosureSEC source: 0001104659-24-039693 · tm249929-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.